Pyridostigmine potentiates l-dopa- but not arginine- and galanin-induced growth hormone secretion in children

Ezio Ghigo, Jaele Bellone, Eliseo Imperiale, Emanuela Aivat, Enrico Mazza, Maria Rosa Valetta, Gian Mario Beffano, Marco Cappa, Sandro Loche, Carlo De Sanctis, Eugenio E. Müller, Franco Camanni

Research output: Contribution to journalArticle

Abstract

The coadministration of growth hormone (GH) secretagogues can provide insight into the neuroregulation of GH secretion. The GH response to L-dopa (125, 250 and 500 mg orally for body weights <15 kg, between 15 and 30 kg and > 30 kg, respectively), arginine (Arg; 0.5 g/kg infused intravenously over 30 min) and galanin (GAL; 15 ug/kg infused intravenously over 60 min) when administered alone or combined with pyridostigmine (PD; 60 mg orally), a cholinergic agonist that likely acts via inhibition of endogenous somatostatin secretion, was studied in children with familial short stature. The GH-releasing effect of PD was also evaluated. In 8 children, PD and L-dopa when administered alone induced an equivalent GH rise (area under the response curve, mean ± SEM: 241.4 ± 31.1 vs. 202.9 ± 38.6 μg/l/h) while their coadministration had an additive effect (435.4 ± 41.4 μg/I/h; p

Original languageEnglish
Pages (from-to)42-45
Number of pages4
JournalNeuroendocrinology
Volume52
Issue number1
DOIs
Publication statusPublished - 1990

Fingerprint

Pyridostigmine Bromide
Galanin
Dihydroxyphenylalanine
Growth Hormone
Arginine
Levodopa
Cholinergic Agonists
Somatostatin
Area Under Curve
Body Weight

Keywords

  • Arginine
  • Children
  • Galanin
  • Growth hormone
  • L-Dopa
  • Pyridostigmine

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Cellular and Molecular Neuroscience
  • Endocrine and Autonomic Systems
  • Neuroscience(all)

Cite this

Ghigo, E., Bellone, J., Imperiale, E., Aivat, E., Mazza, E., Valetta, M. R., ... Camanni, F. (1990). Pyridostigmine potentiates l-dopa- but not arginine- and galanin-induced growth hormone secretion in children. Neuroendocrinology, 52(1), 42-45. https://doi.org/10.1159/000125536

Pyridostigmine potentiates l-dopa- but not arginine- and galanin-induced growth hormone secretion in children. / Ghigo, Ezio; Bellone, Jaele; Imperiale, Eliseo; Aivat, Emanuela; Mazza, Enrico; Valetta, Maria Rosa; Beffano, Gian Mario; Cappa, Marco; Loche, Sandro; De Sanctis, Carlo; Müller, Eugenio E.; Camanni, Franco.

In: Neuroendocrinology, Vol. 52, No. 1, 1990, p. 42-45.

Research output: Contribution to journalArticle

Ghigo, E, Bellone, J, Imperiale, E, Aivat, E, Mazza, E, Valetta, MR, Beffano, GM, Cappa, M, Loche, S, De Sanctis, C, Müller, EE & Camanni, F 1990, 'Pyridostigmine potentiates l-dopa- but not arginine- and galanin-induced growth hormone secretion in children', Neuroendocrinology, vol. 52, no. 1, pp. 42-45. https://doi.org/10.1159/000125536
Ghigo, Ezio ; Bellone, Jaele ; Imperiale, Eliseo ; Aivat, Emanuela ; Mazza, Enrico ; Valetta, Maria Rosa ; Beffano, Gian Mario ; Cappa, Marco ; Loche, Sandro ; De Sanctis, Carlo ; Müller, Eugenio E. ; Camanni, Franco. / Pyridostigmine potentiates l-dopa- but not arginine- and galanin-induced growth hormone secretion in children. In: Neuroendocrinology. 1990 ; Vol. 52, No. 1. pp. 42-45.
@article{aeb4df6d70364404bdff1a71718e6295,
title = "Pyridostigmine potentiates l-dopa- but not arginine- and galanin-induced growth hormone secretion in children",
abstract = "The coadministration of growth hormone (GH) secretagogues can provide insight into the neuroregulation of GH secretion. The GH response to L-dopa (125, 250 and 500 mg orally for body weights <15 kg, between 15 and 30 kg and > 30 kg, respectively), arginine (Arg; 0.5 g/kg infused intravenously over 30 min) and galanin (GAL; 15 ug/kg infused intravenously over 60 min) when administered alone or combined with pyridostigmine (PD; 60 mg orally), a cholinergic agonist that likely acts via inhibition of endogenous somatostatin secretion, was studied in children with familial short stature. The GH-releasing effect of PD was also evaluated. In 8 children, PD and L-dopa when administered alone induced an equivalent GH rise (area under the response curve, mean ± SEM: 241.4 ± 31.1 vs. 202.9 ± 38.6 μg/l/h) while their coadministration had an additive effect (435.4 ± 41.4 μg/I/h; p",
keywords = "Arginine, Children, Galanin, Growth hormone, L-Dopa, Pyridostigmine",
author = "Ezio Ghigo and Jaele Bellone and Eliseo Imperiale and Emanuela Aivat and Enrico Mazza and Valetta, {Maria Rosa} and Beffano, {Gian Mario} and Marco Cappa and Sandro Loche and {De Sanctis}, Carlo and M{\"u}ller, {Eugenio E.} and Franco Camanni",
year = "1990",
doi = "10.1159/000125536",
language = "English",
volume = "52",
pages = "42--45",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Pyridostigmine potentiates l-dopa- but not arginine- and galanin-induced growth hormone secretion in children

AU - Ghigo, Ezio

AU - Bellone, Jaele

AU - Imperiale, Eliseo

AU - Aivat, Emanuela

AU - Mazza, Enrico

AU - Valetta, Maria Rosa

AU - Beffano, Gian Mario

AU - Cappa, Marco

AU - Loche, Sandro

AU - De Sanctis, Carlo

AU - Müller, Eugenio E.

AU - Camanni, Franco

PY - 1990

Y1 - 1990

N2 - The coadministration of growth hormone (GH) secretagogues can provide insight into the neuroregulation of GH secretion. The GH response to L-dopa (125, 250 and 500 mg orally for body weights <15 kg, between 15 and 30 kg and > 30 kg, respectively), arginine (Arg; 0.5 g/kg infused intravenously over 30 min) and galanin (GAL; 15 ug/kg infused intravenously over 60 min) when administered alone or combined with pyridostigmine (PD; 60 mg orally), a cholinergic agonist that likely acts via inhibition of endogenous somatostatin secretion, was studied in children with familial short stature. The GH-releasing effect of PD was also evaluated. In 8 children, PD and L-dopa when administered alone induced an equivalent GH rise (area under the response curve, mean ± SEM: 241.4 ± 31.1 vs. 202.9 ± 38.6 μg/l/h) while their coadministration had an additive effect (435.4 ± 41.4 μg/I/h; p

AB - The coadministration of growth hormone (GH) secretagogues can provide insight into the neuroregulation of GH secretion. The GH response to L-dopa (125, 250 and 500 mg orally for body weights <15 kg, between 15 and 30 kg and > 30 kg, respectively), arginine (Arg; 0.5 g/kg infused intravenously over 30 min) and galanin (GAL; 15 ug/kg infused intravenously over 60 min) when administered alone or combined with pyridostigmine (PD; 60 mg orally), a cholinergic agonist that likely acts via inhibition of endogenous somatostatin secretion, was studied in children with familial short stature. The GH-releasing effect of PD was also evaluated. In 8 children, PD and L-dopa when administered alone induced an equivalent GH rise (area under the response curve, mean ± SEM: 241.4 ± 31.1 vs. 202.9 ± 38.6 μg/l/h) while their coadministration had an additive effect (435.4 ± 41.4 μg/I/h; p

KW - Arginine

KW - Children

KW - Galanin

KW - Growth hormone

KW - L-Dopa

KW - Pyridostigmine

UR - http://www.scopus.com/inward/record.url?scp=0025193486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025193486&partnerID=8YFLogxK

U2 - 10.1159/000125536

DO - 10.1159/000125536

M3 - Article

C2 - 1697660

AN - SCOPUS:0025193486

VL - 52

SP - 42

EP - 45

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 1

ER -